Join us on Saturday, January 23rd, 2021, at 12:00 pm EST for a webinar featuring a discussion of how gene therapies can be used to address retinal degenerative diseases, as well as the latest updates on gene therapy research and clinical trials.
Since its founding in 1971, the Foundation Fighting Blindness has been dedicated to funding innovative research to find preventions, treatments, and cures for inherited retinal degenerative diseases that lead to blindness and affect more than 10 million people in the United States.
The Foundation currently funds over 134 research studies and 71 prominent research institutions and eye hospitals worldwide, including 15 dedicated research centers. In order to achieve our mission, we fund pioneering research in a comprehensive program that approaches possible cures and treatments from every promising angle.
Thanks to supporters like you, the Foundation has already restored vision in some clinical trial participants… and we’re committed to having a total of 30 clinical trials underway by 2030. We can now feel absolutely confident telling parents of young children that we will have better treatments – and even a cure – in their child’s lifetime.
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.
Welcome to the Foundation site — supported in partnership with Genentech, A Member of the Roche Group.